John Wray
Family Medicine · Abilene, TXNPI 1700882230
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 558 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,198 and has fallen 99.3% since, to $15 in 2023. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 558 payments — averaging $12.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- GSK$1K
- AbbVie$972
- AstraZeneca$834
- Lilly USA, LLC$359
- Amgen$344
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,810100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 133 | $1,148 |
| GSK | 78 | $1,007 |
| AbbVie(2 entities) | 80 | $972 |
| AstraZeneca | 44 | $834 |
| Lilly USA, LLC | 36 | $359 |
| Amgen | 21 | $344 |
| Amarin Pharma, Inc. | 22 | $270 |
| Pfizer | 26 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $158 |
| Boehringer Ingelheim | 9 | $157 |
| Biohaven Pharmaceuticals, Inc. | 18 | $157 |
| Merck | 10 | $135 |
| Astellas Pharma US Inc | 5 | $99 |
| Boston Scientific | 2 | $84 |
| Sanofi Pasteur Inc. | 6 | $81 |
| Johnson & Johnson(2 entities) | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 5 | $72 |
| Genentech USA, Inc. | 4 | $71 |
| Abbott | 3 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $66 |
| Nestle Healthcare Nutrition Inc. | 5 | $65 |
| Currax Pharmaceuticals LLC | 5 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| Novartis | 3 | $42 |
| Eisai Inc. | 2 | $34 |
| Zyla Life Sciences, Inc. | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 2 | $24 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Shire North American Group Inc | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,824 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Abilene
- Martha WalkeAbilene$266K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.